Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Cash flows from operating activities
Net loss	$ (345,108)	$ (132,241)	$ (197,024)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	25,050	16,457	10,083
Non-cash operating lease cost	4,739	4,244	3,762
Stock-based compensation	93,350	67,331	4,947
Amortization of deferred contract acquisition costs	2,361	1,786	1,206
Transaction costs expensed	0	7,031	0
Change in fair value of contingent earnout liability	0	(84,420)	0
Other	16,832	374	1,858
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net	(94,600)	(38,388)	3,292
Inventories	(39,358)	(1,991)	(9,585)
Prepaid expenses and other assets	(37,969)	(23,941)	(8,914)
Operating lease liabilities	(5,043)	(3,460)	(2,815)
Accounts payable	31,476	7,933	(493)
Accrued and other liabilities	29,394	21,619	11,556
Deferred revenue	51,803	55,281	17,156
Net cash used in operating activities	(267,049)	(157,178)	(91,846)
Cash flows from investing activities
Purchases of property and equipment	(18,563)	(16,410)	(11,484)
Purchases of investments	(284,835)	0	0
Maturities of investments	180,000	0	47,014
Cash paid for acquisition, net of cash acquired	(2,756)	(205,330)	0
Net cash provided by (used in) investing activities	(126,154)	(221,740)	35,530
Cash flows from financing activities
Proceeds from issuance of redeemable convertible preferred stock	0	0	95,456
Proceeds from the exercise of public warrants	6,884	118,864	0
Merger and PIPE financing	0	511,646	0
Payment of tax withholding obligations on settlement of earnout shares	0	(20,895)	0
Repayment of borrowings	0	(36,051)	0
Proceeds from issuance of common stock warrants, net of issuance costs	0	0	31,547
Proceeds from issuance of debt, net of issuance costs	293,972	0	0
Payments of transaction costs related to Merger	0	(32,468)	0
Change in driver funds and amounts due to customers	11,107	3,675	0
Payment of deferred transaction costs	0	0	(4,003)
Proceeds from issuance of stock in connection with stock plans, net of withholding taxes	11,446	4,916	5,913
Proceeds from issuance of common stock in connection with ATM offerings	49,450	0	0
Net cash provided by financing activities	372,859	549,687	128,913
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(729)	(1,025)	141
Net increase (decrease) in cash, cash equivalents, and restricted cash	(21,073)	169,744	72,738
Cash, cash equivalents, and restricted cash at beginning of period	315,635	145,891	73,153
Cash, cash equivalents, and restricted cash at end of period	294,562	315,635	145,891
Supplementary cash flow information
Cash paid for interest	4,929	346	2,801
Cash paid for taxes	598	268	172
Supplementary cash flow information on non-cash investing and financing activities
Accretion of beneficial conversion feature of redeemable convertible preferred stock	0	0	60,377
Deferred transaction costs not yet paid	0	0	1,685
Right-of-use assets obtained in exchange for lease liabilities	0	7,991	2,118
Right-of-use asset remeasurement subsequent to lease extension	0	0	12,867
Acquisitions of property and equipment included in accounts payable and accrued and other current liabilities	1,954	660	647
Vesting of early exercised stock options	69	178	268
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization	0	615,697	0
Reclassification of Legacy ChargePoint redeemable convertible preferred stock warrant liability upon the reverse capitalization	0	66,606	0
Contingent earnout liability recognized upon the closing of the reverse recapitalization	0	828,180	0
Reclassification of remaining contingent earnout liability upon triggering event	0	242,640	0
Issuance of common stock in connection with acquisitions	0	102,057	0
ViriCiti
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of contingent earnout liability	0	2,266	0
Common stock warrant
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of warrant liabilities	24	(47,822)	0
Redeemable convertible preferred stock warrant
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of warrant liabilities	$ 0	$ (9,237)	$ 73,125